Saul B. Helman
Saul B. Helman, MD, MBA
Dr. Saul B. Helman is President of Epsilon Life Sciences and specializes in risk management, compliance, monitorships, litigation and investigations, bringing over two decades of life sciences experience, both in management roles and consulting, to complex client needs.
Saul spends most of his professional consulting time providing support in investigations, litigation, compliance monitorships and compliance integration matters involving life sciences companies. Applying his knowledge secured through working in international marketing and clinical development in industry, Saul has led projects involving expert witness testimony, litigation support, compliance implementation and assessment and investigation support. Saul has led the support of clients and external counsel with investigations of fraud and abuse in the industry.
Saul's experience includes the development and implementation of global healthcare compliance programs, support of clients through Deferred Prosecution Agreements and Corporate Integrity Agreements, Pre-IRO support, Board and Executive level support through compliance program implementation or evaluation, auditing and monitoring of healthcare compliance programs, support of outside counsel through complex litigation matters including off-label promotion, clinical data management and disclosure, fraud and abuse (False Claims Act, Anti-Kickback Statute and Foreign Corrupt Practices Act) and aggregate spend reporting (Physician Payment Sunshine Act). In addition, Saul has conducted risk assessments and remediation of manufacturing, regulatory, clinical, marketing and sales departments.
Prior to his consulting career, Saul has led a number of organizations across the healthcare continuum, including a global medical staffing organization in the United Kingdom, a home health/home infusion/durable medical equipment/prosthetics and orthotics company in Indiana, and running a rural healthcare clinic in South Africa. Saul has also led the global launch of pharmaceuticals, international new product planning and various therapeutic area strategies in the bio-pharmaceutical industry.
Saul holds an MBBCh (MD) and Bachelor of Science from the University of the Witwatersrand and an MBA from Oxford Brookes University. Saul serves on the Board of The Peace Learning Center.